Bruce Brown is Senior Vice President, Therapeutic Area Head Urologic Oncology at Aura. Dr. Brown is responsible for leading the bladder cancer program, including the current ongoing trial, as well as driving future strategy and development plans. He joins Aura from Myovant Sciences, where he was Vice President, Clinical Development. Prior to Myovant, Bruce was the Chief Medical Officer at Dendreon Pharmacetuicals. He previously held positions of increasing responsibility at several biotech and healthcare companies including Astellas Pharma and Baxter Healthcare. Dr. Brown is a board-certified urologist and joined the pharmaceutical industry after practicing urology for 17 years. He obtained his M.D. from University of Illinois College of Medicine and his A.B. in history from Stanford University.